Πολιτικές αύξησης της διείσδυσης των γενόσημων φαρμάκων στην Ελλάδα: εστίαση στα ψυχικά νοσήματα

Αποστολίδης, Δημήτριος

Policies to increase the penetration of generic drugs in Greece: focus on mental illness

Master Thesis

Author

Αποστολίδης, Δημήτριος

Date

2020

Abstract

In the context of the present thesis, an attempt is being made to capture the pharmaceutical policy that has been implemented in recent years in Greece with the ultimate goal of increasing the share of generic drugs and restraining public pharmaceutical spending. The purpose of the thesis is to highlight the dysfunctions of the generics’ drugs pharmaceutical policy in Greece, the attention that the state should pay to the phenomenon of multiplication of the mentally ill and the submission of innovative proposals for the operational functioning of the pharmaceutical system. Initially, a bibliographical review and recent data analysis is performed on a theoretical level. In the first chapter are mentioned demographic data and forecasts of Greece and the countries of the European Union. Evidence on the therapeutic equivalence of generic-original drugs is, also, provided. The second chapter highlights the benefits of the penetration of generic drugs for public health systems worldwide. Subsequently, there is a comparison of Greece with selected countries. In the third chapter, an analysis of the financing sectors of the country's pharmaceutical system is done, while in the fourth the terms "rebate" and "clawback" are explained. The pharmaceutical policy implemented in Greece with the aim of developing the generic market is presented in the fifth chapter. Then, in the sixth chapter, a comparison is made with the corresponding policies that are applied internationally. In the seventh and last chapter is the research part of the thesis. Initially, the reason for the focus on mental illness markets is explained. The following is the purpose, methodology and results of the primary research followed by IQVIA data processing on the active substances olanzapine and escitalopram in the period 2014-2018. After that, a discussion follows, based on the results of the research, where solutions are proposed to reduce pharmaceutical spending by simultaneously increasing Greek GDP. Finally, a new form of calculating the closed budget of public outpatient pharmaceutical expenditure is suggested.

Postgraduate Studies Programme

Οικονομικά και Διοίκηση της Υγείας

Department

Σχολή Οικονομικών, Επιχειρηματικών και Διεθνών Σπουδών. Τμήμα Οικονομικής Επιστήμης

Number of pages

183

Language

Greek

URI

https://dione.lib.unipi.gr/xmlui/handle/unipi/12838
http://dx.doi.org/10.26267/unipi_dione/261

Collections

Τμήμα Οικονομικής Επιστήμης

Show full item record

Except where otherwise noted, this item's license is described as
Attribution-NonCommercial-NoDerivatives 4.0 Διεθνές